hpv 16/18 vaccine (Cervarix) Report issue

Vaccine Approved FDA
AACT MeSH PubChem

Active Ingredient History

NOW
  • Now
Cervarix is a vaccine against certain types of cancer-causing human papillomavirus (HPV).   Wikipedia

Chemistry

More Chemistry

Pharmacology

  • Mechanism of Action:
  • Multi-specific: Missing data
  • Black Box: Missing data
  • Availability: Missing data
  • Delivery Methods: Missing data
  • Pro Drug: Missing data

Alternative names

bivalent hpv vaccine | cervarix | gardasil | gsk580299 | hpv 16/18 vaccine | hpv-6/11/16/18 vaccine | hpv l1 vaccine, bivalent 16,18 | hpv vaccine for strains -6, -11, -16, and -18 | human papillomavirus 16/18 virus-like particle | human papillomavirus1 type 16 l1 protein / human papillomavirus type 18 l1 protein | human papillomavirus bivalent [types 16 and 18] vaccine | human papillomavirus bivalent (types 16 and 18) vaccine, recombinant | human papillomavirus vaccine l1 16,18 | human papillomavirus vaccine, l1 type 16, 18 | human papillomavirus virus 16/18 bivalent vaccine | medi 517 | medi-517 | ta-hpv

Organizations (46)

Research & Development (46)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (1)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (24)

Approved Indications (1)


 

Papillomavirus Infections (approved 2009)

Experimental Indications - Clinical Trial Phases 1-4 (24)


 

Alphapapillomavirus (Phase 4)

Arthritis, Juvenile (Phase 4)

Carcinoma (Phase 1)

Cervical Intraepithelial Neoplasia (Phase 4)

Condylomata Acuminata (Phase 3)

Dengue (Phase 3)

Dermatomyositis (Phase 4)

Healthy Volunteers (Phase 4)

HIV (Phase 4)

HIV Infections (Phase 2)

Human papillomavirus 16 (Phase 3)

Lupus Erythematosus, Systemic (Phase 4)

Meningococcal Infections (Phase 3)

Papillomaviridae (Phase 3)

Papillomavirus Infections (Phase 4)

Papillomavirus Vaccines (Phase 4)

Persistent Infection (Phase 4)

Pharmacological and Toxicological Phenomena (Phase 3)

Precancerous Conditions (Phase 3)

Severe Dengue (Phase 3)

Uterine Cervical Neoplasms (Phase 4)

Vaginal Neoplasms (Phase 4)

Vulvar Neoplasms (Phase 4)

Warts (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 84
  • # of Trial Organizations: 46

Trials by Phase

Trial Phase Start Date Organizations Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue